Instrument NameSmall Pharma IncInstrument Symbol(DMT-X)

Instrument ExchangeTSX Venture

Small Pharma is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used...

Announces that SPL026, intravenous N,N-Dimethyltryptamine, with supportive therapy for the treatment ...

Further Composition of Matter protection for SPL028, the Company’s next candidate expected to enter the clinic...

Key U.S. patent protection on injectable delivery of DMT in lead programs SPL026 and SPL028 LONDON, July 26, 2022 (GLOBE NEWSWIRE) -- Small Pharma...

Building on strong foundations to take Small Pharma through development to commercial success Peter Rands to take on role as Chief Innovation &...

Progress continues apace with multiple trials expected to enter clinic later this year First US patent granted LONDON, July 15, 2022 (GLOBE NEWSWIRE)...

Small Pharma is among the group of TSX Venture Exchange companies currently trading at less than cash value. This means companies whose current share price is less than the cash per share on their balance sheet or stocks with more cash than market...

LONDON, United Kingdom, June 22, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology...

Reporting its financial results and continued progress across short-acting psychedelics portfolio Executive team and IP position strengthened LONDON,...

LONDON, May 30, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused...